Best Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician Considerations

• Published in: Plastic and reconstructive surgery. Global open Vol. 9; no. 7; p. e3668
• Main Authors: Teller, Craig F., Chiu, Annie, Chesnut, Cameron D., Sherman, Deborah, Raul Montes, José, Gaspard, Sara, Keaney, Terrence, Sadick, Neil S., Yoelin, Steve, Sangha, Sara, Shridharani, Sachin M.
• Format: Journal Article
• Language: English
• Published: United States Lippincott Williams & Wilkins 12-07-2021; Wolters Kluwer
• Subjects: Cosmetic; Original
• ISSN: 2169-7574; 2169-7574
• DOI: 10.1097/GOX.0000000000003668

Submental fat can be reduced with ATX-101 (deoxycholic acid injection), a customizable and minimally invasive alternative to liposuction. In the years since its approval, the treatment patterns of ATX-101 have evolved.
A panel of experienced physicians from the United States gathered to generate best practices for the use of ATX-101 in submental contouring.
The expert panel provided their insights on appropriate patient selection, managing patient expectations of ATX-101 treatment outcomes, and adverse events, and guidance on ATX-101 administration for optimal outcomes are presented here.
These best clinical practices on the use of ATX-101 for the reduction of submental fat should enable physicians to enhance the patient treatment experience and outcomes.